ATE44130T1 - Pharmazeutische produkte mit einem gehalt an magnesiumtrisilikat-adsorbens mit darauf adsorbiertem heilmittelwirkstoff. - Google Patents

Pharmazeutische produkte mit einem gehalt an magnesiumtrisilikat-adsorbens mit darauf adsorbiertem heilmittelwirkstoff.

Info

Publication number
ATE44130T1
ATE44130T1 AT83306756T AT83306756T ATE44130T1 AT E44130 T1 ATE44130 T1 AT E44130T1 AT 83306756 T AT83306756 T AT 83306756T AT 83306756 T AT83306756 T AT 83306756T AT E44130 T1 ATE44130 T1 AT E44130T1
Authority
AT
Austria
Prior art keywords
adsorbent
magnesium trisilicate
adsorbed onto
active substance
products containing
Prior art date
Application number
AT83306756T
Other languages
German (de)
English (en)
Inventor
David Peters
Anil K Talwar
John Denick Jr
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE44130T1 publication Critical patent/ATE44130T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • External Artificial Organs (AREA)
  • Luminescent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heat Treatment Of Steel (AREA)
AT83306756T 1983-07-20 1983-11-07 Pharmazeutische produkte mit einem gehalt an magnesiumtrisilikat-adsorbens mit darauf adsorbiertem heilmittelwirkstoff. ATE44130T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/516,002 US4581232A (en) 1983-07-20 1983-07-20 Magnesium trisilicate suitable for preparation of medicament adsorbates
EP83306756A EP0132472B1 (en) 1983-07-20 1983-11-07 Medicated products containing a magnesium trisilicate adsorbent with a medicament drug adsorbed thereon

Publications (1)

Publication Number Publication Date
ATE44130T1 true ATE44130T1 (de) 1989-07-15

Family

ID=24053698

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83306756T ATE44130T1 (de) 1983-07-20 1983-11-07 Pharmazeutische produkte mit einem gehalt an magnesiumtrisilikat-adsorbens mit darauf adsorbiertem heilmittelwirkstoff.

Country Status (13)

Country Link
US (1) US4581232A (enExample)
EP (1) EP0132472B1 (enExample)
JP (1) JPS60112722A (enExample)
AT (1) ATE44130T1 (enExample)
AU (1) AU563740B2 (enExample)
CA (1) CA1207232A (enExample)
DE (1) DE3380090D1 (enExample)
DK (1) DK159805C (enExample)
ES (1) ES8607723A1 (enExample)
FI (1) FI79785C (enExample)
IE (1) IE56510B1 (enExample)
NZ (1) NZ206101A (enExample)
ZA (1) ZA838080B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413191D0 (en) * 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4758424A (en) * 1986-03-27 1988-07-19 Warner-Lambert Company Medicament adsorbates of decongestants with complex magnesium aluminum silicate and their preparation
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4758425A (en) * 1986-03-27 1988-07-19 Warner-Lambert Company Medicament adsorbates of antiasthmatics with complex magnesium aluminum silicate and their preparation
US4761274A (en) * 1986-03-27 1988-08-02 Warner-Lambert Company Medicament adsorbates of analgesics with complex magnesium aluminum silicate and their preparation
US4711774A (en) * 1986-03-27 1987-12-08 Warner-Lambert Company Medicament adsorbates with complex magnesium aluminum silicate and their preparation
US4717565A (en) * 1986-03-27 1988-01-05 Warner-Lambert Company Process for the preparation of medicament adsorbates
US4820523A (en) * 1986-04-15 1989-04-11 Warner-Lambert Company Pharmaceutical composition
US5468482A (en) * 1987-07-17 1995-11-21 Calam & Associates, Inc. Palatable orally administered liquid medicaments for relief of discomfort and flavoring combinations therefor
US5891801A (en) * 1987-07-17 1999-04-06 Calam And Associates, Inc. Palatable liquid-admininstered oral medicaments for relief of discomfort and flavoring combinations therefor
JP2535707Y2 (ja) * 1991-04-05 1997-05-14 日本精工株式会社 リニアガイド装置のストッパ装置
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
WO1995003785A1 (en) * 1993-08-03 1995-02-09 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
US5626878A (en) * 1995-01-10 1997-05-06 Warner Lambert Company Reduction of electrostatic forces between magnesium trisilicate adsorbates
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
NZ529490A (en) * 2001-06-22 2005-08-26 Pfizer Prod Inc Pharmaceutical compositions of adsorbates of amorphous drug
ES2305434T3 (es) 2002-02-01 2008-11-01 Pfizer Products Inc. Composiciones framaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
CA2532931A1 (en) * 2003-08-04 2005-02-10 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
DK1566173T3 (da) * 2004-02-20 2006-12-27 Mattern Udo Farmaceutisk sammensætning til oral anvendelse og fremgangsmåde til fremstilling deraf
AU2005315291A1 (en) * 2004-12-13 2006-06-22 Mcneil-Ppc, Inc. Compositions and methods for stabilizing active pharmaceutical ingredients
US20090098192A1 (en) * 2007-10-11 2009-04-16 Fuisz Richard C Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same
MY153890A (en) 2007-10-11 2015-04-15 Philip Morris Products Sa Smokeless tobacco product
US9125434B2 (en) * 2007-10-11 2015-09-08 Philip Morris Products S.A. Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet
EP2244699A2 (en) * 2008-01-31 2010-11-03 Mcneil-PPC, Inc Edible film-strips for immediate release of active ingredients
WO2009099831A2 (en) * 2008-01-31 2009-08-13 Mcneil-Ppc, Inc. Edible film-strips with modified release active ingredients
CN110330023B (zh) * 2019-07-17 2020-10-13 云鹏医药集团有限公司 一种三硅酸镁的制备及干燥方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR799950A (fr) * 1935-03-27 1936-06-23 Mutosel Procédé de préparation de silicates complexes de bases organiques
US2881113A (en) * 1957-01-29 1959-04-07 Ortho Pharma Corp Therapeutically active compositions containing amphetamines
US3085942A (en) * 1960-12-28 1963-04-16 Hoffmann La Roche Antitussive compositions and preparation
US3352752A (en) * 1963-07-25 1967-11-14 Tintex Corp Intestinal adsorbent compositions
US3337402A (en) * 1963-09-03 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical composition
US3337403A (en) * 1963-09-05 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical compositions
US3449266A (en) * 1964-05-25 1969-06-10 Drackett Co Stabilized solid granular perfume composition
US3272594A (en) * 1965-10-22 1966-09-13 Merck & Co Inc Preparation of magnesium trisilicate
US3567819A (en) * 1969-01-30 1971-03-02 Hoffmann La Roche Cold tablet
US3636200A (en) * 1969-06-09 1972-01-18 Hoffmann La Roche Pharmaceutical suspension
GB1236880A (en) * 1969-12-20 1971-06-23 Exp Drugs Company Antacid compositions
DE2217652A1 (de) * 1972-04-12 1973-10-18 Paolo Dr Sorbini Lyophilisierte arzneimittelprodukte und verfahren zu ihrer herstellung
DE2631947B2 (de) * 1976-07-15 1980-11-27 Bayer Ag, 5090 Leverkusen Verwendung von ätherischen ölen und Äthylalkohol
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
IL58462A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a penicillin
JPS5594315A (en) * 1979-01-11 1980-07-17 Taiyo Yakuhin Kogyo Kk Antibacterial drug
JPS55129224A (en) * 1979-03-27 1980-10-06 Toyo Jozo Co Ltd Fine granules having improved taste
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation

Also Published As

Publication number Publication date
AU2068983A (en) 1985-01-24
NZ206101A (en) 1985-09-13
DK553283D0 (da) 1983-12-01
FI840615L (fi) 1985-01-21
ES8607723A1 (es) 1986-06-01
IE56510B1 (en) 1991-08-28
JPS60112722A (ja) 1985-06-19
IE832545L (en) 1985-01-20
DK159805C (da) 1991-05-06
US4581232A (en) 1986-04-08
FI79785C (fi) 1990-03-12
JPH0465811B2 (enExample) 1992-10-21
ES526990A0 (es) 1986-06-01
DK159805B (da) 1990-12-10
AU563740B2 (en) 1987-07-23
DK553283A (da) 1985-01-21
FI79785B (fi) 1989-11-30
FI840615A0 (fi) 1984-02-15
CA1207232A (en) 1986-07-08
EP0132472B1 (en) 1989-06-21
ZA838080B (en) 1984-06-27
EP0132472A1 (en) 1985-02-13
DE3380090D1 (en) 1989-07-27

Similar Documents

Publication Publication Date Title
ATE44130T1 (de) Pharmazeutische produkte mit einem gehalt an magnesiumtrisilikat-adsorbens mit darauf adsorbiertem heilmittelwirkstoff.
EP0724885A4 (en) COMPOSITION ADMINISTERED BY NASAL AND PREPARATION CONTAINING THE SAME
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
ATE77947T1 (de) Pentamidin enthaltende pharmazeutische zusammensetzungen.
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
NZ228970A (en) Chewable tablet comprising granules and an extragranular hygroscopic excipient
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
PH25545A (en) Sustained release multi-granule tablet
ES8705763A1 (es) Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos
IE781117L (en) Medicament comprising erythromycin and metoclopramide
Prakash Lithium-responsive schizophrenia
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
RU93016030A (ru) Лекарственное средство, стимулирующее гранулоцитарный росток кроветворения при цитостатических миелодепрессиях
EP0173145A3 (en) Reduction of the toxic effects caused by anthraquinone drugs
JPS646214A (en) Remedy for ulcerative colonopathy
SE8106498L (sv) Kvaternera salter av n,n3-di(beta-brompropionyl)-n1,n2-dispirotripiperazinium, forfarande for framstellning av desamma och lekemedelspreparat innehallande desamma
IE45282L (en) Pharmaceutical tablet formulation
EP0132772A3 (en) Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
RU94022543A (ru) Основа лекарственного средства и способ ее изготовления
JPS6413026A (en) Antiviral agent

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time